Friday - March 29, 2024
3-(4-((4-(Morpholinomethyl-Benzyl)oxy)-1 -Oxoisoindolin-2-Yl)piperidine-2,6-Dione for the Treatment of Systemic Lupus Erythematosus
Copyright © Targeted News Service, 2023
2023-05-30
ALEXANDRIA, Virginia, May 30 -- CELGENE CORPORATION, Summit, New Jersey has been assigned a patent (No. US 11660302 B2, initially filed March 29, 2021) developed by three inventors Peter H. Schafer, Belle Mead, New Jersey; Lei Wu, Bridgewater, New Jersey; and Ying Ye, Branchburg, New Jersey, for "3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus." . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information or a free trial

Copyright Targeted News Service 2023